Rheumatoid synovial fibroblast constitutively express the fibrinolytic pattern of invasive tumor-like cells

Clinical and Experimental Rheumatology

Volumn 23, Issue 3, 2005, Pages 364-372

  Guiducci, Serena ^a   Del Rosso, Angela ^a   Cinelli, Marina ^a   Margheri, Francesca ^a   D'Alessio, Silvia ^a   Fibbi, Gabriella ^a   Cerinic, Marco Matucci ^a   Del Rosso, Mario ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Fibrinolytic system; Invasion; PAI 1; Proliferation; Rheumatoid arthritis; Synovial fibroblasts; uPA; uPAR

Indexed keywords

MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; UROKINASE; UROKINASE RECEPTOR; CELL SURFACE RECEPTOR; PLASMINOGEN ACTIVATOR, UROKINASE RECEPTORS;

ADULT; ARTICLE; CASE REPORT; CELL COUNT; CELL CULTURE; CELL DIVISION; CELL FUNCTION; CELL GROWTH; CELL LYSATE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOLYSIS; FIBROBLAST; GENE OVEREXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; ZYMOGRAPHY; CELL MOTION; CHEMOTAXIS; DOSE RESPONSE; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; SYNOVIUM;

ADULT; ARTHRITIS, RHEUMATOID; CELL MOVEMENT; CELL PROLIFERATION; CHEMOTAXIS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOLYSIS; FIBROBLASTS; GENE EXPRESSION; HUMANS; MALE; PLASMINOGEN ACTIVATOR INHIBITOR 1; RECEPTORS, CELL SURFACE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SYNOVIAL MEMBRANE; URINARY PLASMINOGEN ACTIVATOR;

EID: 20444486170     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. MIGNATTI P, RIFKIN DB: Biology and biochemistry of proteinase in tumor invasion. Physiol Rev 1993; 73: 161-95.
2. BOUCK N, STELLMACH V, HSU SC: How tumors become angiogenetic. Adv Cancer Res 1996; 69: 135-74.
3. HOLLANDER AP, DIEPPE PA, ATKINS RM, ELSON CJ: Cartilage catabolic cofactors in human arthritis. J Rheumatol 1993; 20: 233-4.
4. DEL ROSSO M, FIBBI G, PUCCI M et al.: Multiple pathways of cell invasion are regulated by multiple families of serine proteases. Clin Exp Metastasis 2002; 19: 193-207.
5. ANDREASEN PA, KJÖLLER L, CHRISTENSEN L, DUFFY MJ: The urokinase-type plasminogen activator system in cancer metastasis: A review. Int J Cancer 1997; 72: 1-22.
6. DANØ K, BEHREND N, BRÜNNER N, ELLIS V, PLOUG M, PYKE C: The urokinase receptor. Protein structure and role in plasminogen activation and cancer invasion. Fibrinolysis 1994; 8 (Suppl. 1): 189-203.
7. WHITELOCK JM, O'GRADY RL, GIBBINS JR: Interstitial collagenase (matrix metallo-proteinase 1) associated with the plasma membrane of both neoplastic and nonneoplastic cells. Invasion Metastasis 1991; 11: 139-48.
8. RONDAY HK, SMITS HH, QUAX PH et al.: Bone matrix degradation by the plasminogen activation system. Possible mechanism of bone destruction in arthritis. Br J Rheumatol 1997; 36: 9-15.
9. DEL ROSSO M, FIBBI G, MATUCCI CERINIC M: The urokinase-type plasminogen activator system and inflammatory joint diseases. Clin Exp Rheumatol 1999; 17: 485-98.
10. MATUCCI CERINIC M, LOMBARDI A, LOTTI T et al.: Fibrinolytic activity of synovial membrane in osteoarthritis. Br J Rheumatol 1990; 29: 249-53.
11. MATUCCI CERINIC M, GENERINI S, PARTSCH G et al.: Synoviocytes from osteoarthritis and rheumatoid arthritis produce plasminogen activators and plasminogen activator inhibitor-1 and display uPA receptor on their surface. Life Sci 1998; 63: 441-53.
12. BUSSO N, PÉCLAT V, SO A, SAPPINO A-P: Plasminogen activation in synovial tissues: differences between normal, osteoarthritis, and rheumatoid arthritis joints. Ann Rheum Dis 1997; 56: 550-7.
13. RONDAY HK, SMITS HH, Van MUIJEN GN et al.: Difference in expression of plasminogen activation system in synovial tissue of patients with rheumatoid arthritis and osteoarthritis. Br J Rheumatol 1996; 35: 416-23.
14. WATANABE N, ANDO K, YOSHIDA S et al.: Gene expression prolife analysis of RA-SF cultures revealing the overexpression of genes responsible for tumor-like growth of rheumatoid synovium. Biochem Biophys Res Commun 2002; 294: 1121-9.
15. BUSSO N, HAMILTON JA: Extravascular coagulation and the plasminogen activator/plasmin system in rheumatoid arthritis. Arthritis Rheum 2002; 46: 2268-79.
16. FIBBI G, ZICHE M, MORBIDELLI L, MAGNELLI L, DEL ROSSO M: Interaction of urokinase with specific receptors stimulates mobilization of bovine adrenal capillary endothelial cells. Exp Cell Res 1988; 179: 385-95.
17. KIRCHHEIMER JC, WOJTA J, CHRIST G, BINDER BR: Proliferation of a human epidermal tumor cell line stimulated by urokinase. FASEB J 1987; 1: 125-8.
18. ANICHINI E, FIBBI G, PUCCI M, CALDINI R, CHEVANNE M, DEL ROSSO M: Production of second messengers following chemotactic and mitogenic urokinase-receptor interaction in human fibroblasts and mouse fibroblasts transfected with human urokinase receptor. Exp Cell Res 1994; 213: 438-48.
19. FIBBI G, MAGNELLI L, PUCCI M, Del ROSSO M: Interaction of urokinase with the receptor of human keratinocytes stimulates release of urokinase-like plasminogen activator. Exp Cell Res 1990; 187: 33-8.
20. JIN T, TARKOWSKI A, CARMELIET P, BOKAREWA M: Urokinase, a constitutive component of the inflamed synovial fluid, induces arthritis. Arthritis Res Ther 2003; 5: R9-R17.
21. FIBBI G, PUCCI M, SERNI U, MATUCCI CERINIC M, DEL ROSSO M: Antisense targeting of the urokinase receptor blocks urokinase-dependent proliferation, chemoinvasion, and chemotaxis of human synovial cells and chondrocytes in vitro. Proc Assoc Am Phys 1998; 110: 340-50.
22. ANDREASEN PA, EGELUND R, PETERSEN HH: The plasminogen activation system in tumor growth, invasion, and metastasis. Cell Mol Life Sci 2000; 57: 25-40.
23. AGUIRRE GHISO JA, KOVALSKI K, OSSOWSKI L: Tumor dormancy induced by down-regulation of urokinase receptor in human carcinoma involves integrin and MAPK signalling. J Cell Biol 1999; 147: 89-104.
24. CHOMCZYNSKI P, SACCHI N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Annal Biochem 1987; 162: 156-9.
25. FIBBI G, BARLETTA E, DINI G et al.: Cell invasion is affected by differential expression of the urokinase plasminogen activator/urokinase plasminogen activator receptor system in muscle satellite cells from normal and dystrophic patients. Lab Invest 2001; 81: 27-39.
26. HART PH, VITTI GF, BURGESS DR, WHITTY GA, ROYSTON K, HAMILTON JA: Activation of human monocytes by granulocyte-macrophage colony-stimulating factor: Increased urokinase-type plasminogen activator activity. Blood 1991; 77: 841-8.
27. HAMILTON JA, SLYVKA J: Stimulation of human synovial fibroblast plasminogen activator production by mononuclear cell supernatants. J Immunol 1981; 126: 851-5.
28. VITTI G, HAMILTON JA: Modulation of urokinase-type plasminogen activator mRNA levels in human synovial fibroblasts by interleukin-1α, retinoic acid, and a glucocorticoid. Arthritis Rheum 1988; 31: 1046-51.
29. BROMMER EJ, DOOIJEWAARD G, DIJKMANS BA, BREEDVELD FC: Plasminogen activators in synovial fluid and plasma from patients with arthritis. Ann Rheum Dis 1992; 51: 965-8.
30. HUANG CM, CHEN CL, TSAI JJ, TSAI CH, TSAI FJ: Association between urokinase gene 3′-UTR T/C polymorphism and Chinese patients with rheumatoid arthritis in Taiwan. Clin Exp Rheumatol 2004; 22: 219-22.
31. SIDENIUS N, BLASI F: The urokinase plasminogen activator system in cancer: Recent advances and implication for prognosis and therapy. Cancer Metastasis Rev 2003; 22: 205-22.
32. DANO K, ROMER J, NIELSEN BS et al.: Cancer invasion and tissue remodeling - cooperation of protease systems and cell types. APMIS 1999; 107: 120-7.
33. DEL ROSSO M, FIBBI G, PUCCI M, MATUCCI CERINIC M: Antisense oligonucleotides against the urokinase receptor: a therapeutic strategy for the control of cell invasion in rheumatoid arthritis and cancer. Clin Exp Rheumatol 1998; 16: 389-93.